Novoron Bioscience To Present at BIO 2024 Conference

San Diego, CA (May, 2024) - Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, will be participating in a range of activities at the upcoming BIO 2024 conference.  

In particular, Novoron CEO – Dr. Travis Stiles – will be presenting at an NIH breakfast session and Novoron Director of Research and Development – David Kochman - will be talking in the NIH Innovation Zone during the meeting.  As only thirty companies were chosen for this prestigious opportunity, it is great recognition for the ground-breaking and innovative work that Novoron are undertaking.

Speaking about the meeting, Dr. Stiles said, “We are really excited to be part of this year's NIH Innovation Zone. The NIH/NIA have been great supporters of our work, especially our newest program developing novel therapeutics for treatment of tauopathies such as Alzheimer's. We are very excited to share our progress publicly for the first time as part of the NIH showcase”.

As well as the formal presentations, Novoron is also excited about the potential networking that can occur during the event, especially considering the meeting is being held in our home city of San Diego.  Indeed, the convention centre is only a short work from Novoron headquarters.  

Novoron’s newly appointed Vice President of Operations, Dr. Kristien Van Vlasselaer, will also be attending the meeting and is looking forward to her first BIO conference in this position.  Discussing the event, Dr. Van Vlasselaer says “BIO 2024 represents an amazing opportunity for us to connect and network with people across the life sciences and biotech community.  We are always looking to engage in discussions that can foster novel collaborations and partnerships.  On a personal level, having recently been promoted to VP of Operations, I'm excited to build relationships and meet new people. If anyone has any interest in Novoron or the CNS indications that we are investigating, I would love to meet and chat - certainly don't hesitate to get in touch”!

About Novoron

Based in San Diego, California, Novoron Bioscience is a private biotechnology company that is focused on the development of novel therapeutics for central nervous system disorders.

Media Contact:

Contact: Brett Drummond

E:  brett.drummond@novoron.com

Ph:  +61 439 636 279

Previous
Previous

Novoron Bioscience Welcomes Dr. David Weiner to the Board of Directors

Next
Next

Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer's Disease